Trials / Completed
CompletedNCT01293552
Clinical Trial To Evaluate ANT-1207 In Subjects With Acne
Clinical Trial To Evaluate Botulinum Neurotoxin Type A (ANT-1207) In Subjects With Acne
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 72 (actual)
- Sponsor
- Anterios Inc. · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to provide evidence of the safety, tolerance, and efficacy of ANT-1207 in the treatment of acne.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | ANT-1207 | single dose application |
| BIOLOGICAL | Vehicle |
Timeline
- Start date
- 2011-01-01
- Primary completion
- 2012-04-01
- Completion
- 2012-07-01
- First posted
- 2011-02-10
- Last updated
- 2013-07-04
Locations
15 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01293552. Inclusion in this directory is not an endorsement.